Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline for Lactation Inhibition After Second Trimester Abortion
NCT06123026Phase 4Completed
- Sponsor
- Northwestern University
- Start
- Dec 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in lactation comparing Cabergoline with Placebo (2 arms). Primary endpoint: Bristol Breast Questionnaire at 2 weeks. Started Dec 2023; status: completed.
02
Drugs
cabergoline
03
Conditions
lactation
Beyond the preview
Go deeper on NCT06123026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06123026.